Qualchem Super V (Dyno Protect prepared version)
The small droplet covers surfaces thoroughly whereas with wet spraying the gaps between droplets could be large enough areas for viruses and bacteria to survive.
We focus on building interiors, office blocks and warehouses and can do inside vehicles as well if required.
Expectations are that residue will kill viruses and bacteria for up to 30 days on surfaces that have not been cleaned after treatment or haven't worn off from use.
• Dust and dirt on treated surfaces (we recommend cleaning prior to sanitisation)
• Sunlight (however sunlight can also kill viruses and bacteria)
• Cleaning off the residue
Sanitiser is applied to walls up to 3m high, return air ducts in ceilings, floors and all equipment (desks, tables, chairs, cupboards, tools etc.). It is not normally applied directly to ceilings unless specified.
We can sanitise up to 10m without platforms if required.
Let us know - our applicators may be able to move things or return for a spot treatment. Items like chairs are mostly turned around to get full cover.
Cover any areas of concern with cover sheets and ask applicators to remove these immediately after treatment while the fog is still in the building.
A fine mist will be left on glass surfaces after treatment. For clear vision you may like to clean this mist however you will be removing the residual action.
We typically fog anywhere 'under canopy' including doorways and building entrances. ULV cold fogging is not an ideal application method for open spaces.
Yes, they often are activated but not always. Have a plan and notify any monitoring service. They normally shut off in about 20 minutes when the fog settles but may need to be reset.
The active ingredient we are using is registered for use in the USA against CoV-2* (the cause of COVID-19) with 10 minutes exposure. While it has not yet been fully tested against this virus, it is expected to be effective based on it
• Demonstrating efficacy against a harder-to-kill virus
• Qualifying for the emerging viral pathogens claim
• Demonstrating efficacy against another human coronavirus similar to SARS-CocV-2
Note: SARS-CoV-2 is a new virus. Such pathogens are often unavailable commercially for laboratory testing**